[1]
Ibrahim, E.M. et al. 2025. Adjuvant Therapy Benefits for Patients With Human Epidermal Growth Factor Receptor 2-Positive T1aN0M0 Breast Cancer: A Systematic Review and Meta-Analysis. World Journal of Oncology. 16, 3 (Jun. 2025), 276–285. DOI:https://doi.org/10.14740/wjon2578.